Recently we (along with Zachary Helms) published a Health Affairs Blog post refuting the pharmaceutical industry argument that the higher prices the industry charges in the US are justified because they are necessary to support research and development
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/07/27/us-drug-prices-and-rd-take-2-a-reply-to-grabowski-and-manning-and-to-light/
Posted
Jul 27 2017, 09:53 AM
by
Health Affairs BlogHealth Affairs Blog